Poly(ethylene imine)-poly(ethylene glycol) copolymers facilitate efficient delivery of antisense oligonucleotides to nuclei of mature muscle cells of mdx mice

Human Gene Therapy

Volumn 16, Issue 11, 2005, Pages 1307-1317

  Sirsi, Shashank R ^a   Williams, Jason H ^a   Lutz, Gordon J ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COPOLYMER; DYSTROPHIN; HOE 33342; INSULIN; MACROGOL; MESSENGER RNA PRECURSOR; POLYETHYLENEIMINE; RHODAMINE; SELENIUM; TRANSFERRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL NUCLEUS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DUCHENNE MUSCULAR DYSTROPHY; ENDOCYTOSIS; FLUORESCENCE ANALYSIS; GENE DELIVERY SYSTEM; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RNA SPLICING; SKELETAL MUSCLE; STATISTICAL ANALYSIS;

ANIMALS; BASE SEQUENCE; CELL NUCLEUS; MICE; MICE, INBRED MDX; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MUSCLE FIBERS; MUSCLES; MUSCULAR DYSTROPHY, DUCHENNE; OLIGONUCLEOTIDES, ANTISENSE; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE;

ANIMALIA;

EID: 27744490361     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.1307     Document Type: Article

References (60)

1. AARTSMA-RUS, A., BREMMER-BOUT, M., JANSON, A.A., DEN DUNNEN, J.T., VAN OMMEN G.J., and VAN DEUTEKOM J.C. (2002). Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy. Neuromuscul. Disord. 12(Suppl. 1), S71-S77.
2. AARTSMA-RUS, A., JANSON, A.A., KAMAN, W.E., BREMMERBOUT, M., DEN DUNNEN, J.T., BAAS, F., VAN OMMEN, G.J., and VAN DEUTEKOM, J.C. (2003). Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients. Hum. Mol. Genet. 12, 907-914.
3. AKINC, A., THOMAS, M., KLIBANOV, A.M., and LANGER, R. (2005). Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J. Gene Med. 7, 657-663.
4. BIEBER, T., MEISSNER, W., KOSTIN, S., NIEMANN, A., and EL-SASSER, H.P. (2002). Intracellular route and transcriptional competence of polyethylenimine-DNA complexes. J. Control. Release 82, 441-454.
5. BOUSSIF, O., LEZOUALC'H, F., ZANTA, M.A., MERGNY, M.D., SCHERMAN, D., DEMENEIX, B., and BEHR, J.P. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 92, 7297-7301.
6. BRAZAS, R.M., and HAGSTROM, J.E. (2005). Delivery of small interfering RNA to mammalian cells in culture by using cationic lipid/polymer-based transfection reagents. Methods Enzymol. 392, 112-124.
7. BREMMER-BOUT, M., AARTSMA-RUS, A., DE MEIJER, E.J., KAMAN, W.E., JANSON, A.A., VOSSEN, R.H., VAN OMMEN, G.J., DEN DUNNEN, J.T., and VAN DEUTEKOM, J.C. (2004). Targeted exon skipping in transgenic hDMD mice: A model for direct preclinical screening of human-specific antisense oligonucleotides. Mol. Ther. 10, 232-240.
8. BRUS, C., PETERSEN, H., AIGNER, A., CZUBAYKO, F., and KISSEL, T. (2004). Physicochemical and biological characterization of polyethylenimine-graft- poly(ethylene glycol) block copolymers as a delivery system for oligonucleotides and ribozymes. Bioconjug. Chem. 15, 677-684.
9. CERLETTI, M., NEGRI, T., COZZI, F., COLPO, R., ANDREETTA, F., CROCI, D., DAVIES, K.E., CORNELIO, F., POZZA, O., KARPATI, G., GILBERT, R., and MORA, M. (2003). Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Ther. 10, 750-757.
10. DASS, C.R. (2002). Vehicles for oligonucleotide delivery to tumours. J. Pharm. Pharmacol. 54, 3-27.
11. DIAS, N., and STEIN, C.A. (2002). Antisense oligonucleotides: Basic concepts and mechanisms. Mol. Cancer Ther. 1, 347-355.
12. DUNCKLEY, M.G., MANOHARAN, M., VILLIET, P., EPERON, I.C., and DICKSON, G. (1998). Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides. Hum. Mol. Genet. 7, 1083-1090.
13. FISCHER, D., OSBURG, B., PETERSEN, H., KISSEL, T., and BICKEL, U. (2004). Effect of poly(ethylene imine) molecular weight and pegylation on organ distribution and pharmacokinetics of polyplexes with oligodeoxynucleotides in mice. Drug Metab. Dispos. 32, 983-992.
14. GEBSKI, B.L., MANN, C.J., FLETCHER, S., and WILTON, S.D. (2003). Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle. Hum. Mol. Genet. 12, 1801-1811.
15. GILCHRIST, S.C., ONTELL, M.P., KOCHANEK, S., and CLEMENS, P.R. (2002). Immune response to full-length dystrophin delivered to DMD muscle by a high-capacity adenoviral vector. Mol. Ther. 6, 359-368.
16. GLODDE, M., SIRSI, S.R., and LUTZ, G.J. (2005). Physiochemical properties of low and high molecular weight PEG-grafted poly(ethylene imine) copolymers and their complexes with oligonucleotides. Submitted.
17. GODBEY, W.T., WU, K.K., and MIKOS, A.G. (1999). Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. U.S.A. 96, 5177-5181.
18. GOODCHILD, J. (2004). Oligonucleotide therapeutics: 25 years agrowing. Curr. Opin. Mol. Ther. 6, 120-128.
19. HARA-CHIKUMA, M., YANG, B., SONAWANE, N.D., SASAKI, S., UCHIDA, S., and VERKMAN, A.S. (2005). ClC-3 chloride channels facilitate endosomal acidification and chloride accumulation. J. Biol. Chem. 280, 1241-1247.
20. HUGHES, M.D., HUSSAIN, M., NAWAZ, Q., SAYYED, P., and AKHTAR, S. (2001). The cellular delivery of antisense oligonucleotides and ribozymes. Drug Discov. Today 6, 303-315.
21. JEONG, J.H., KIM, S.W., and PARK, T.G. (2003). A new antisense oligonucleotide delivery system based on self-assembled ODN-PEG hybrid conjugate micelles. J. Control. Release 93, 183-191.
22. JIANG, Z., SCHIEDNER, G., VAN, R.N., LIU, C.C., KOCHANEK, S., and CLEMENS, P.R. (2004). Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade. Mol. Ther. 10, 688-696.
23. KAISTO, T., RAHKILA, P., MARJOMAKI, V., PARTON, R.G., and METSIKKO, K. (1999). Endocytosis in skeletal muscle fibers. Exp. Cell Res. 253, 551-560.
24. KICHLER, A. (2004). Gene transfer with modified polyethylenimines. J. Gene Med. 6(Suppl. 1), S3-10.
25. KUNATH, K., VON, H.A., PETERSEN, H., FISCHER, D., VOIGT, K., KISSEL, T., and BICKEL, U. (2002). The structure of PEG-modified poly(ethylene imines) influences biodistribution and pharmacokinetics of their complexes with NF-κB decoy in mice. Pharm. Res. 19, 810-817.
26. KURRECK, J. (2003). Antisense technologies: Improvement through novel chemical modifications. Eur. J. Biochem. 270, 1628-1644.
27. LIANG, K.W., HOFFMAN, E.P., and HUANG, L. (2000). Targeted delivery of plasmid DNA to myogenic cells via transferrin-conjugated peptide nucleic acid. Mol. Ther. 1, 236-243.
28. LU, Q.L., MANN, C.J., LOU, F., BOU-GHARIOS, G., MORRIS, G.E., XUE, S.A., FLETCHER, S., PARTRIDGE, T.A., and WILTON, S.D. (2003). Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nat. Med. 9, 1009-1014.
29. LU, Q.L., RABINOWITZ, A., CHEN, Y.C., YOKOTA, T., YIN, H., ALTER, J., JADOON, A., BOU-GHARIOS, G., and PARTRIDGE, T. (2005). From the cover: Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc. Natl. Acad. Sci. U.S.A. 102, 198-203.
30. MANN, C.J., HONEYMAN, K., CHENG, A.J., LY, T., LLOYD, F., FLETCHER, S., MORGAN, J.E., PARTRIDGE, T.A., and WILTON, S.D. (2001). Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc. Natl. Acad. Sci. U.S.A. 98, 42-47.
31. MARCUSSON, E.G., YACYSHYN, B.R., SHANAHAN, W.R., Jr., and DEAN, N.M. (1999). Preclinical and clinical pharmacology of antisense oligonucleotides. Mol. Biotechnol. 12, 1-11.
32. MARSHALL, E. (1999). Gene therapy death prompts review of adenovirus vector. Science 286, 2244-2245.
33. MERDAN, T., KOPECEK, J., and KISSEL, T. (2002). Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug Deliv. Rev. 54, 715-758.
34. MUKHERJEE, S., GHOSH, R.N., and MAXFIELD, F.R. (1997). Endocytosis. Physiol. Rev. 77, 759-803.
35. OGRIS, M., WALKER, G., BLESSING, T., KIRCHEIS, R., WOLSCHEK, M., and WAGNER, E. (2003). Tumor-targeted gene therapy: Strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J. Control. Release 91, 173-181.
36. OPALINSKA, J.B., and GEWIRTZ, A.M. (2002). Nucleic acid therapeutics: Basic principles and recent applications. Nat. Rev. Drug Discov. 1, 503-514.
37. PETERSEN, H., FECHNER, P.M., FISCHER, D., and KISSEL, T. (2002a). Synthesis, characterization, and biocompatibility of polyethylenimine-graft- poly(ethylene glycol) block copolymers. Macromolecules 35, 6867-6874.
38. PETERSEN, H., FECHNER, P.M., MARTIN, A.L., KUNATH, K., STOLNIK, S., ROBERTS, C.J., FISCHER, D., DAVIES, M.C., and KISSEL, T. (2002b). Polyethylenimine-graft-poly(ethylene glycol) copolymers: Influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug. Chem. 13, 845-854.
39. RAVICHANDRAN, L.V., DEAN, N.M., and MARCUSSON, E.G. (2004). Use of antisense oligonucleotides in functional genomics and target validation. Oligonucleotides 14, 49-64.
40. REJMAN, J., BRAGONZI, A., and CONESE, M. (2005). Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. Mol. Ther. 12, 468-474.
41. REMY-KRISTENSEN, A., CLAMME, J.P., VUILLEUMIER, C., KUHRY, J.G., and MELY, Y. (2001). Role of endocytosis in the transfection of L929 fibroblasts by polyethylenimine/DNA complexes. Biochim. Biophys. Acta 1514, 21-32.
42. ROSENBLATT, J.D., LUNT, A.I., PARRY, D.J., and PARTRIDGE, T.A. (1995). Culturing satellite cells from living single muscle fiber explants. In Vitro Cell Dev. Biol. Anim. 31, 773-779.
43. ROTH, C.M., and SUNDARAM, S. (2004). Engineering synthetic vectors for improved DNA delivery: Insights from intracellular pathways. Annu. Rev. Biomed. Eng. 6, 397-426.
44. SAZANI, P., and KOLE, R. (2003). Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. J. Clin. Invest. 112, 481-486.
45. SCHIFFELERS, R.M., ANSARI, A., XU, J., ZHOU, Q., TANG, Q., STORM, G., MOLEMA, G., LU, P.Y., SCARIA, P.V., and WOODLE, M.C. (2004). Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 32, e149.
46. SEMPLE, S.C., HARASYM, T.O., CLOW, K.A., ANSELL, S.M., KLMUK, S.K., and HOPE, M.J. (2005). Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid. J. Pharmacol. Exp. Ther. 312, 1020-1026.
47. SHI, F., and HOEKSTRA, D. (2004). Effective intracellular delivery of oligonucleotides in order to make sense of antisense. J. Control. Release 97, 189-209.
48. SONAWANE, N.D., SZOKA, F.C., JR., and VERKMAN, A.S. (2003). Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. Biol. Chem. 278, 44826-44831.
49. SUH, J., WIRTZ, D., and HANES, J. (2003). Efficient active transport of gene nanocarriers to the cell nucleus. Proc. Natl. Acad. Sci. U.S.A. 100, 3878-3882.
50. SUNG, S.J., MIN, S.H., CHO, K.Y., LEE, S., MIN, Y.J., YEOM, Y.I., and PARK, J.K. (2003). Effect of polyethylene glycol on gene delivery of polyethylenimine. Biol. Pharm. Bull. 26, 492-500.
51. THOMAS, M., and KLIBANOV, A.M. (2003). Non-viral gene therapy: Polycation-mediated DNA delivery. Appl. Microbiol. Biotechnol. 62, 27-34.
52. ULRICH, A.S. (2002). Biophysical aspects of using liposomes as delivery vehicles. Biosci. Rep. 22, 129-150.
53. VAN DEUTEKOM, J.C. (2005). Gene therapy: The "pro-sense" approach to Duchenne muscular dystrophy. Eur. J. Hum. Genet. 13, 518-519.
54. VAN DEUTEKOM, J.C., BREMMER-BOUT, M., JANSON, A.A., GINJAAR, I.E., BAAS, F., DEN DUNNEN, J.T., and VAN OMMEN, G.J. (2001). Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum. Mol. Genet. 10, 1547-1554.
55. VINOGRADOV, S., BATRAKOVA, E., LI, S., and KABANOV, A. (1999). Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells. Bioconjug. Chem. 10, 851-860.
56. VINOGRADOV, S.V., BRONICH, T.K., and KABANOV, A.V. (1998). Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides. Bioconjug. Chem. 9, 805-812.
57. VINOGRADOV, S.V., BATRAKOVA, E.V., and KABANOV, A.V. (2004). Nanogels for oligonucleotide delivery to the brain. Bioconjug. Chem. 15, 50-60.
58. WELLS, K.E., FLETCHER, S., MANN, C.J., WILTON, S.D., and WELLS, D.J. (2003). Enhanced in vivo delivery of antisense oligonucleotides to restore dystrophin expression in adult mdx mouse muscle. FEBS Lett. 552, 145-149.
59. WIETHOFF, C.M., and MIDDAUGH, C.R. (2003). Barriers to nonviral gene delivery. J. Pharm. Sci. 92, 203-217.
60. ZAISS, A.K., and MURUVE, D.A. (2005). Immune responses to adeno-associated virus vectors. Curr. Gene Ther. 5, 323-331.